Department of molecular pharmacology and cancer therapeutics. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy12

Cell Line, Tumor HCT116 Cells Tumor Cells, Cultured Cell Line HeLa Cells Neoplastic Stem Cells Breast Prostate HEK293 Cells MCF-7 Cells Cells, Cultured HT29 Cells

Organisms4

Mice, Nude Mice, SCID Mice, Inbred BALB C Mice, Inbred C57BL

Diseases42

Neoplasms Breast Neoplasms Prostatic Neoplasms Lung Neoplasms Cell Transformation, Neoplastic Ovarian Neoplasms Neovascularization, Pathologic Colonic Neoplasms Stomach Neoplasms Disease Models, Animal Neoplasm Metastasis Neoplasm Invasiveness Pancreatic Neoplasms Disease Progression Uterine Cervical Neoplasms Genetic Predisposition to Disease Carcinoma Carcinoma, Squamous Cell Carcinoma, Non-Small-Cell Lung Urinary Bladder Neoplasms Colorectal Neoplasms Neoplasm Recurrence, Local Rectal Neoplasms Emergencies Endometrial Neoplasms Esophageal Neoplasms Adenocarcinoma Head and Neck Neoplasms Liver Neoplasms Mouth Neoplasms Bone Neoplasms Wounds and Injuries Skin Neoplasms Neoplasms, Hormone-Dependent Drug-Related Side Effects and Adverse Reactions Neoplasms, Glandular and Epithelial Carcinoma, Small Cell Neoplasms, Radiation-Induced Neoplasms, Second Primary Genital Neoplasms, Female Pain Precancerous Conditions

Chemicals and Drugs49

Receptors, G-Protein-Coupled Ligands Antineoplastic Agents Protein Kinase Inhibitors RNA, Small Interfering Neoplasm Proteins Small Molecule Libraries Enzyme Inhibitors Antibodies, Monoclonal Inhibitor of Apoptosis Proteins Receptor, erbB-2 Tumor Suppressor Protein p53 RNA, Messenger Histone Deacetylase Inhibitors Receptor, Epidermal Growth Factor HSP90 Heat-Shock Proteins Piperazines Benzamides Pyrimidines Cancer Vaccines Angiogenesis Inhibitors Peptides Proto-Oncogene Proteins c-bcl-2 Protein-Serine-Threonine Kinases Tumor Markers, Biological Receptors, Estrogen DNA, Neoplasm Pharmaceutical Preparations Antineoplastic Agents, Phytogenic Fluorouracil Prostate-Specific Antigen MicroRNAs Tamoxifen Cisplatin Paclitaxel Receptors, Progesterone Antigens, Neoplasm Drug Carriers Antineoplastic Agents, Hormonal Anticarcinogenic Agents Antimetabolites, Antineoplastic Antibodies, Monoclonal, Humanized Tumor Suppressor Proteins Deoxycytidine DNA-Binding Proteins Recombinant Proteins Quinazolines Proto-Oncogene Proteins Proto-Oncogene Proteins c-akt

Analytical, Diagnostic and Therapeutic Techniques and Equipment69

Drug Delivery Systems Molecular Targeted Therapy Drug Design Xenograft Model Antitumor Assays Drug Discovery Clinical Trials as Topic Early Detection of Cancer Therapeutics Drug Screening Assays, Antitumor Models, Biological Drug Evaluation, Preclinical Inhibitory Concentration 50 Immunotherapy Neoplasm Transplantation Transplantation, Heterologous Tumor Burden Retrospective Studies Blotting, Western Transfection Disease Models, Animal Prospective Studies Genetic Therapy Flow Cytometry Prognosis Follow-Up Studies Survival Analysis Reverse Transcriptase Polymerase Chain Reaction Survival Rate Risk Assessment Questionnaires Models, Molecular Gene Expression Profiling Antineoplastic Combined Chemotherapy Protocols Risk Registries Risk Factors Sensitivity and Specificity Treatment Outcome Neoplasm Staging Combined Modality Therapy Odds Ratio Reproducibility of Results Disease-Free Survival Predictive Value of Tests Multivariate Analysis Oligonucleotide Array Sequence Analysis Logistic Models Incidence Chemotherapy, Adjuvant Polymerase Chain Reaction Kaplan-Meier Estimate Drug Therapy Confidence Intervals Mammography Individualized Medicine Drug Administration Schedule Drug Carriers Gene Knockdown Techniques SEER Program Pilot Projects Immunohistochemistry Tomography, X-Ray Computed Diagnostic Imaging Cohort Studies Emergency Treatment Radiotherapy Neoplasm Grading Tissue Array Analysis Administration, Oral

Psychiatry and Psychology2

Phenomena and Processes44

Signal Transduction Gene Expression Regulation, Neoplastic Apoptosis Drug Resistance, Neoplasm Cell Proliferation Cell Survival Dose-Response Relationship, Drug RNA Interference Inhibitory Concentration 50 Mutation Transfection Protein Binding Down-Regulation Drug Synergism Cell Division Amino Acid Sequence DNA Damage Structure-Activity Relationship Protein Structure, Tertiary Phosphorylation Genetic Predisposition to Disease Risk Time Factors Binding Sites Sensitivity and Specificity Odds Ratio DNA Methylation Cell Movement Genotype Cell Cycle Gene Silencing Polymorphism, Genetic Up-Regulation Cell Growth Processes Gene Expression Base Sequence Genes, BRCA1 Promoter Regions, Genetic Phenotype Pharmacokinetics Genes, Tumor Suppressor Genes, Neoplasm Pain Genes, p53

Disciplines and Occupations12

Pharmacology, Clinical Pharmacology Drug Design Drug Discovery Nanomedicine Medical Oncology Emergency Medicine Individualized Medicine Pharmacogenetics Emergency Nursing Immunohistochemistry Biomedical Research

Anthropology, Education, Sociology and Social Phenomena5

National Cancer Institute (U.S.)United States Department of Veterans Affairs United States Department of Defense Age Distribution Quality of Life

Technology, Industry, Agriculture2

Nanomedicine Nanoparticles

Humanities2

History, 20th Century Quality of Life

Information Science10

Molecular Sequence Data Amino Acid Sequence Survival Rate Questionnaires Registries Incidence Base Sequence SEER Program Terminology as Topic Databases, Factual

Named Groups1

Health Care45

Emergency Service, Hospital Clinical Trials as Topic Hospital Departments Retrospective Studies Prospective Studies Pharmacy and Therapeutics Committee Follow-Up Studies Survival Analysis Survival Rate Risk Assessment Questionnaires Age Factors National Cancer Institute (U.S.)Risk United States Department of Veterans Affairs Registries Risk Factors Radiology Department, Hospital Sensitivity and Specificity Treatment Outcome Odds Ratio Reproducibility of Results Emergencies Disease-Free Survival Predictive Value of Tests Multivariate Analysis Triage Logistic Models United States Department of Defense Incidence Emergency Medical Services Kaplan-Meier Estimate Public Health Administration Confidence Intervals Pathology Department, Hospital International Agencies Age Distribution SEER Program Pilot Projects Emergency Nursing Cohort Studies American Cancer Society Societies, Pharmaceutical Practice Guidelines as Topic Sex Factors

Geographicals6

United States Great Britain England Japan California China

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Humanities Information Science Named Groups Health Care Geographicals

Receptors, G-Protein-Coupled Ligands Signal Transduction Neoplasms Pharmacology, Clinical Pharmacology Antineoplastic Agents Cell Line, Tumor Drug Delivery Systems Molecular Targeted Therapy Emergency Service, Hospital Drug Design Xenograft Model Antitumor Assays Gene Expression Regulation, Neoplastic Mice, Nude Breast Neoplasms Drug Discovery Clinical Trials as Topic Prostatic Neoplasms Apoptosis Drug Resistance, Neoplasm Nanomedicine Early Detection of Cancer Therapeutics Cell Proliferation Protein Kinase Inhibitors Drug Screening Assays, Antitumor RNA, Small Interfering Nanoparticles Lung Neoplasms Models, Biological Neoplasm Proteins Drug Evaluation, Preclinical Cell Survival Small Molecule Libraries Enzyme Inhibitors Dose-Response Relationship, Drug Hospital Departments Antibodies, Monoclonal RNA Interference Inhibitor of Apoptosis Proteins Inhibitory Concentration 50 Immunotherapy Cell Transformation, Neoplastic Receptor, erbB-2 Ovarian Neoplasms HCT116 Cells Tumor Suppressor Protein p53 Neoplasm Transplantation Mutation Transplantation, Heterologous United States Tumor Burden RNA, Messenger Neovascularization, Pathologic Retrospective Studies Colonic Neoplasms Blotting, Western Transfection Stomach Neoplasms Disease Models, Animal Histone Deacetylase Inhibitors Neoplasm Metastasis Molecular Sequence Data Mice, SCID Protein Binding Neoplasm Invasiveness Receptor, Epidermal Growth Factor Prospective Studies Pharmacy and Therapeutics Committee Genetic Therapy HSP90 Heat-Shock Proteins Down-Regulation Pancreatic Neoplasms Tumor Cells, Cultured Piperazines Benzamides Drug Synergism Pyrimidines Cell Line Cell Division Cancer Vaccines Angiogenesis Inhibitors Amino Acid Sequence Peptides Flow Cytometry Prognosis Follow-Up Studies DNA Damage Structure-Activity Relationship Protein Structure, Tertiary Phosphorylation Survival Analysis Reverse Transcriptase Polymerase Chain Reaction Proto-Oncogene Proteins c-bcl-2 Survival Rate Risk Assessment Disease Progression Questionnaires Models, Molecular

No FAQ available that match "department of molecular pharmacology and cancer therapeutics"